Insider Transactions in Q2 2021 at Idexx Laboratories Inc (IDXX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2021
|
Jonathan W Ayers Director |
SELL
Open market or private sale
|
Direct |
9,460
-0.29%
|
$5,316,520
$562.57 P/Share
|
|
May 28
2021
|
Jonathan W Ayers Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,460
+1.43%
|
$747,340
$79.54 P/Share
|
|
May 28
2021
|
James F Polewaczyk Executive Vice President |
SELL
Open market or private sale
|
Direct |
10,000
-4.92%
|
$5,620,000
$562.27 P/Share
|
|
May 28
2021
|
James F Polewaczyk Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.05%
|
$670,000
$67.85 P/Share
|
|
May 28
2021
|
Kathy V Turner Senior Vice President |
SELL
Open market or private sale
|
Direct |
2,000
-40.93%
|
$1,116,000
$558.44 P/Share
|
|
May 25
2021
|
Jonathan W Ayers Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.38%
|
$2,760,000
$552.74 P/Share
|
|
May 25
2021
|
Jonathan W Ayers Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.75%
|
$395,000
$79.54 P/Share
|
|
May 24
2021
|
Jonathan W Ayers Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.76%
|
$2,730,000
$546.98 P/Share
|
|
May 24
2021
|
Jonathan W Ayers Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.75%
|
$395,000
$79.54 P/Share
|
|
May 24
2021
|
Kathy V Turner Senior Vice President |
SELL
Open market or private sale
|
Direct |
2,900
-20.36%
|
$1,586,300
$547.0 P/Share
|
|
May 21
2021
|
Daniel M Junius Director |
SELL
Open market or private sale
|
Direct |
2,500
-46.42%
|
$1,347,500
$539.57 P/Share
|
|
May 21
2021
|
Daniel M Junius Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+31.7%
|
$212,500
$85.0 P/Share
|
|
May 21
2021
|
Kathy V Turner Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,000
-11.41%
|
$545,000
$545.0 P/Share
|
|
May 20
2021
|
Jonathan W Ayers Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.25%
|
$2,685,000
$537.41 P/Share
|
|
May 20
2021
|
Jonathan W Ayers Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.75%
|
$395,000
$79.54 P/Share
|
|
May 20
2021
|
Kathy V Turner Senior Vice President |
SELL
Open market or private sale
|
Direct |
2,000
-9.76%
|
$1,074,000
$537.5 P/Share
|
|
May 18
2021
|
Jonathan W Ayers Director |
SELL
Open market or private sale
|
Direct |
7,632
-1.15%
|
$4,029,696
$528.01 P/Share
|
|
May 18
2021
|
Jonathan W Ayers Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,632
+1.14%
|
$602,928
$79.54 P/Share
|
|
May 18
2021
|
Jonathan Jay Mazelsky President and CEO |
SELL
Bona fide gift
|
Direct |
500
-0.9%
|
-
|
|
May 12
2021
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
9,000
-1.38%
|
-
|
|
May 10
2021
|
Jonathan W Ayers Director |
SELL
Open market or private sale
|
Direct |
512
-0.04%
|
$276,992
$541.74 P/Share
|
|
Apr 30
2021
|
Asha Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
36
+31.58%
|
$19,728
$548.99 P/Share
|
|
Apr 30
2021
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
36
+3.38%
|
$19,728
$548.99 P/Share
|
|
Apr 30
2021
|
Daniel M Junius Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.38%
|
$6,028
$548.99 P/Share
|